25 XP   0   0   10

Icosavax Inc
Buy, Hold or Sell?

Let's analyse Icosavax together

PenkeI guess you are interested in Icosavax Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Icosavax Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Icosavax Inc

I send you an email if I find something interesting about Icosavax Inc.

Quick analysis of Icosavax (30 sec.)










What can you expect buying and holding a share of Icosavax? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.34
Expected worth in 1 year
$-0.44
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$-4.78
Return On Investment
-31.2%

For what price can you sell your share?

Current Price per Share
$15.31
Expected price per share
$15.17 - $15.78
How sure are you?
50%

1. Valuation of Icosavax (5 min.)




Live pricePrice per Share (EOD)

$15.31

Intrinsic Value Per Share

$-22.91 - $-27.46

Total Value Per Share

$-18.57 - $-23.12

2. Growth of Icosavax (5 min.)




Is Icosavax growing?

Current yearPrevious yearGrowGrow %
How rich?$218.1m$278.2m-$60m-27.5%

How much money is Icosavax making?

Current yearPrevious yearGrowGrow %
Making money-$88.4m-$67.9m-$20.4m-23.1%
Net Profit Margin-15,199.0%-871.6%--

How much money comes from the company's main activities?

3. Financial Health of Icosavax (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#239 / 1010

Most Revenue
#539 / 1010

Most Profit
#959 / 1010

Most Efficient
#953 / 1010

What can you expect buying and holding a share of Icosavax? (5 min.)

Welcome investor! Icosavax's management wants to use your money to grow the business. In return you get a share of Icosavax.

What can you expect buying and holding a share of Icosavax?

First you should know what it really means to hold a share of Icosavax. And how you can make/lose money.

Speculation

The Price per Share of Icosavax is $15.31. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Icosavax.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Icosavax, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.34. Based on the TTM, the Book Value Change Per Share is $-1.20 per quarter. Based on the YOY, the Book Value Change Per Share is $6.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Icosavax.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.83-11.9%-1.83-11.9%-1.33-8.7%-0.91-6.0%-0.91-6.0%
Usd Book Value Change Per Share-1.20-7.8%-1.20-7.8%6.0739.6%1.097.1%1.097.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.20-7.8%-1.20-7.8%6.0739.6%1.097.1%1.097.1%
Usd Price Per Share7.94-7.94-22.88-7.71-7.71-
Price to Earnings Ratio-4.35--4.35--17.16--5.38--5.38-
Price-to-Total Gains Ratio-6.64--6.64-3.77--1.44--1.44-
Price to Book Ratio1.83-1.83-4.13-1.49-1.49-
Price-to-Total Gains Ratio-6.64--6.64-3.77--1.44--1.44-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.31
Number of shares65
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.201.09
Usd Total Gains Per Share-1.201.09
Gains per Quarter (65 shares)-77.7270.58
Gains per Year (65 shares)-310.87282.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-311-3210282272
20-622-6320565554
30-933-9430847836
40-1243-1254011291118
50-1554-1565014121400
60-1865-1876016941682
70-2176-2187019761964
80-2487-2498022582246
90-2798-2809025412528
100-3109-3120028232810

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.00.00.0%0.04.00.00.0%0.04.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%

Fundamentals of Icosavax

About Icosavax Inc

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington. As of February 19, 2024, Icosavax, Inc. operates as a subsidiary of AstraZeneca PLC.

Fundamental data was last updated by Penke on 2024-04-11 11:26:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Icosavax Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Icosavax earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Icosavax to the Biotechnology industry mean.
  • A Net Profit Margin of -15,199.0% means that $-151.99 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Icosavax Inc:

  • The MRQ is -15,199.0%. The company is making a huge loss. -2
  • The TTM is -15,199.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15,199.0%TTM-15,199.0%0.0%
TTM-15,199.0%YOY-871.6%-14,327.4%
TTM-15,199.0%5Y-4,314.4%-10,884.5%
5Y-4,314.4%10Y-4,314.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15,199.0%-200.1%-14,998.9%
TTM-15,199.0%-216.8%-14,982.2%
YOY-871.6%-288.3%-583.3%
5Y-4,314.4%-449.1%-3,865.3%
10Y-4,314.4%-605.5%-3,708.9%
1.1.2. Return on Assets

Shows how efficient Icosavax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Icosavax to the Biotechnology industry mean.
  • -37.1% Return on Assets means that Icosavax generated $-0.37 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Icosavax Inc:

  • The MRQ is -37.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -37.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-37.1%TTM-37.1%0.0%
TTM-37.1%YOY-23.6%-13.4%
TTM-37.1%5Y-50.4%+13.4%
5Y-50.4%10Y-50.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.1%-13.3%-23.8%
TTM-37.1%-12.8%-24.3%
YOY-23.6%-11.7%-11.9%
5Y-50.4%-13.9%-36.5%
10Y-50.4%-15.7%-34.7%
1.1.3. Return on Equity

Shows how efficient Icosavax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Icosavax to the Biotechnology industry mean.
  • -40.5% Return on Equity means Icosavax generated $-0.41 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Icosavax Inc:

  • The MRQ is -40.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -40.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.5%TTM-40.5%0.0%
TTM-40.5%YOY-24.4%-16.1%
TTM-40.5%5Y-16.2%-24.3%
5Y-16.2%10Y-16.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.5%-16.9%-23.6%
TTM-40.5%-16.1%-24.4%
YOY-24.4%-15.1%-9.3%
5Y-16.2%-19.3%+3.1%
10Y-16.2%-20.2%+4.0%

1.2. Operating Efficiency of Icosavax Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Icosavax is operating .

  • Measures how much profit Icosavax makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Icosavax to the Biotechnology industry mean.
  • An Operating Margin of -16,333.0% means the company generated $-163.33  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Icosavax Inc:

  • The MRQ is -16,333.0%. The company is operating very inefficient. -2
  • The TTM is -16,333.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16,333.0%TTM-16,333.0%0.0%
TTM-16,333.0%YOY-844.2%-15,488.8%
TTM-16,333.0%5Y-4,583.7%-11,749.3%
5Y-4,583.7%10Y-4,583.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16,333.0%-296.2%-16,036.8%
TTM-16,333.0%-232.5%-16,100.5%
YOY-844.2%-298.2%-546.0%
5Y-4,583.7%-492.1%-4,091.6%
10Y-4,583.7%-632.4%-3,951.3%
1.2.2. Operating Ratio

Measures how efficient Icosavax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 166.50 means that the operating costs are $166.50 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Icosavax Inc:

  • The MRQ is 166.497. The company is inefficient in keeping operating costs low. -1
  • The TTM is 166.497. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ166.497TTM166.4970.000
TTM166.497YOY8.452+158.045
TTM166.4975Y49.365+117.132
5Y49.36510Y49.3650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ166.4973.231+163.266
TTM166.4973.310+163.187
YOY8.4523.890+4.562
5Y49.3655.739+43.626
10Y49.3657.876+41.489

1.3. Liquidity of Icosavax Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Icosavax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 16.24 means the company has $16.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Icosavax Inc:

  • The MRQ is 16.240. The company is very able to pay all its short-term debts. +2
  • The TTM is 16.240. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ16.240TTM16.2400.000
TTM16.240YOY31.019-14.779
TTM16.2405Y17.268-1.028
5Y17.26810Y17.2680.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.2403.890+12.350
TTM16.2404.173+12.067
YOY31.0195.344+25.675
5Y17.2686.126+11.142
10Y17.2686.448+10.820
1.3.2. Quick Ratio

Measures if Icosavax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Icosavax to the Biotechnology industry mean.
  • A Quick Ratio of 27.40 means the company can pay off $27.40 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Icosavax Inc:

  • The MRQ is 27.398. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 27.398. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ27.398TTM27.3980.000
TTM27.398YOY30.210-2.812
TTM27.3985Y19.682+7.717
5Y19.68210Y19.6820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.3983.514+23.884
TTM27.3983.998+23.400
YOY30.2105.380+24.830
5Y19.6826.105+13.577
10Y19.6826.404+13.278

1.4. Solvency of Icosavax Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Icosavax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Icosavax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Icosavax assets are financed with 8.6% credit (debt) and the remaining percentage (100% - 8.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Icosavax Inc:

  • The MRQ is 0.086. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.086. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.086TTM0.0860.000
TTM0.086YOY0.033+0.053
TTM0.0865Y1.031-0.945
5Y1.03110Y1.0310.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0860.339-0.253
TTM0.0860.336-0.250
YOY0.0330.271-0.238
5Y1.0310.366+0.665
10Y1.0310.389+0.642
1.4.2. Debt to Equity Ratio

Measures if Icosavax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Icosavax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 9.4% means that company has $0.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Icosavax Inc:

  • The MRQ is 0.094. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.094. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.0940.000
TTM0.094YOY0.034+0.060
TTM0.0945Y0.032+0.062
5Y0.03210Y0.0320.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0940.388-0.294
TTM0.0940.402-0.308
YOY0.0340.335-0.301
5Y0.0320.426-0.394
10Y0.0320.461-0.429

2. Market Valuation of Icosavax Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Icosavax generates.

  • Above 15 is considered overpriced but always compare Icosavax to the Biotechnology industry mean.
  • A PE ratio of -4.35 means the investor is paying $-4.35 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Icosavax Inc:

  • The EOD is -8.381. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.347. Based on the earnings, the company is expensive. -2
  • The TTM is -4.347. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.381MRQ-4.347-4.035
MRQ-4.347TTM-4.3470.000
TTM-4.347YOY-17.161+12.814
TTM-4.3475Y-5.377+1.030
5Y-5.37710Y-5.3770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.381-2.264-6.117
MRQ-4.347-2.629-1.718
TTM-4.347-2.680-1.667
YOY-17.161-4.145-13.016
5Y-5.377-6.257+0.880
10Y-5.377-6.254+0.877
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Icosavax Inc:

  • The EOD is -10.565. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.479. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.479. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.565MRQ-5.479-5.086
MRQ-5.479TTM-5.4790.000
TTM-5.479YOY-29.062+23.583
TTM-5.4795Y-8.635+3.156
5Y-8.63510Y-8.6350.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.565-2.973-7.592
MRQ-5.479-3.333-2.146
TTM-5.479-3.553-1.926
YOY-29.062-5.605-23.457
5Y-8.635-8.376-0.259
10Y-8.635-8.865+0.230
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Icosavax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.83 means the investor is paying $1.83 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Icosavax Inc:

  • The EOD is 3.525. Based on the equity, the company is fair priced.
  • The MRQ is 1.828. Based on the equity, the company is underpriced. +1
  • The TTM is 1.828. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.525MRQ1.828+1.697
MRQ1.828TTM1.8280.000
TTM1.828YOY4.131-2.303
TTM1.8285Y1.490+0.338
5Y1.49010Y1.4900.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.5251.896+1.629
MRQ1.8282.115-0.287
TTM1.8282.093-0.265
YOY4.1312.884+1.247
5Y1.4903.542-2.052
10Y1.4903.916-2.426
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Icosavax Inc.

3.1. Institutions holding Icosavax Inc

Institutions are holding 87.635% of the shares of Icosavax Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31RA Capital Management, LLC11.87231.468596356500
2023-12-31T. Rowe Price Investment Management,Inc.7.81670.04023926407-909244-18.8029
2023-12-31TCG Crossover Management, LLC7.37336.4734370370400
2023-12-31Qiming U.S. Ventures Management, LLC6.988250.6563351022800
2023-12-31Pentwater Capital Management LP5.97240.5301300000030000000
2023-12-31BlackRock Inc5.13930.001258153058525029.317
2023-12-31FMR Inc4.46040.00272240524-3213424-58.9192
2023-12-31Vanguard Group Inc3.64330.00061830058-68229-3.5942
2023-12-31Vivo Capital, LLC3.39352.1996170456800
2023-09-30Citadel Advisors Llc3.19080.00271602772-582238-26.6469
2023-12-31Eckert Corp2.91.1772145670014567000
2023-12-31Junked Platinum Investment Management Ltd2.74850.88351380618-955374-40.898
2023-12-31Water Island Capital LLC1.74391.41418760008760000
2023-12-31Rock Springs Capital Management LP1.72880.336986840900
2023-09-30LAURION CAPITAL MANAGEMENT LP1.47790.035174235400
2023-12-31Geode Capital Management, LLC1.41210.0012709322289434.254
2023-12-31State Street Corporation1.23030.00056179998396615.723
2023-12-31Goldman Sachs Group Inc1.17850.00085919685631321952.8783
2023-12-31Segantii Capital Management Ltd1.02530.42485150005150000
2023-12-31Test Hedge Fund Mgmt1.00960.99775071225071220
Total 76.305166.646438328848+1887604+4.9%

3.2. Funds holding Icosavax Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31T. Rowe Price Small-Cap Value2.47050.18491240955-216700-14.8663
2023-12-31T. Rowe Price US Small-Cap Core Equity1.37770.115692056-181100-20.7409
2023-12-31T. Rowe Price Small-Cap Stock1.37770.1153692056-181100-20.7409
2023-12-31T. Rowe Price U.S. SC Value Eq Tr-Z1.27140.2038638655-84500-11.6849
2023-12-31T. Rowe Price U.S. SC Core Eq Tr-Z0.85150.1445427718285007.139
2023-12-31T. Rowe Price Instl Small-Cap Stock0.64110.1153322039-86500-21.173
2023-12-31T. Rowe Price US Smlr Cm Eq A USD0.58960.1636296169-108568-26.8243
2024-01-31Fidelity Small Cap Index0.55180.017127716831881.1636
2023-12-31AQR Diversified Arbitrage I0.20280.08861018701018700
2023-12-31iMGP Alt Strats Instl0.18150.228791174911740
2023-09-30BlackRock Extended Mkt Composite0.16560.0046831793727181.1863
2023-12-31NT R2000 Value Index Fund - NL0.16040.03368057813121.6552
2023-12-31NT R2000 Index Fund - NL0.15930.01748000714061.7888
2023-12-31Fidelity NorthStar Sr F0.13540.03646800000
2023-12-31NT R2000 Index Fund - DC - NL - 20.12540.0174630068681.3969
2023-12-31Northern Trust Russell 2000 Value Index0.11030.03375539429115.5466
2023-12-31NT R2000 Value Index Fund - L0.11030.03345539429115.5466
2024-01-31TIAA-CREF Equity Index Instl0.1010.00195075100
2024-03-31Russell 2000 Index Non-Lendable Fund E0.09510.000347782-2417-4.8148
2024-03-31BlackRock Russell 2500™ Index F0.08460.000142514170.04
Total 10.7631.55565406465-589457-10.9%

3.3. Insider Transactions

Insiders are holding 3.472% of the shares of Icosavax Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-01Adam K SimpsonSELL1500015.29
2024-01-04Niranjan Kanesa-thasanSELL10637315.7
2024-01-02Adam K SimpsonSELL1500015.67
2023-12-21Adam K SimpsonSELL9000015.44
2023-12-20Niranjan Kanesa-thasanSELL1188415.46
2023-12-20Thomas Joseph RussoSELL1518315.46
2023-12-13Cassia CearleySELL875916.01
2023-07-31Adam K SimpsonSELL117888.86
2023-07-31Niranjan Kanesa-thasanSELL33238.86
2023-07-31Thomas Joseph RussoSELL30668.86
2023-07-03Douglas HoltzmanSELL163568.85
2023-05-23Cassia CearleySELL1000010

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Icosavax Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.196-1.1960%6.070-120%1.086-210%1.086-210%
Book Value Per Share--4.3434.3430%5.539-22%2.297+89%2.297+89%
Current Ratio--16.24016.2400%31.019-48%17.268-6%17.268-6%
Debt To Asset Ratio--0.0860.0860%0.033+163%1.031-92%1.031-92%
Debt To Equity Ratio--0.0940.0940%0.034+178%0.032+194%0.032+194%
Dividend Per Share----0%-0%-0%-0%
Eps---1.827-1.8270%-1.333-27%-0.914-50%-0.914-50%
Free Cash Flow Per Share---1.449-1.4490%-0.787-46%-0.653-55%-0.653-55%
Free Cash Flow To Equity Per Share---1.244-1.2440%5.280-124%1.082-215%1.082-215%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---27.462--------
Intrinsic Value_10Y_min---22.914--------
Intrinsic Value_1Y_max---1.255--------
Intrinsic Value_1Y_min---1.219--------
Intrinsic Value_3Y_max---4.911--------
Intrinsic Value_3Y_min---4.618--------
Intrinsic Value_5Y_max---9.943--------
Intrinsic Value_5Y_min---9.037--------
Market Cap769036610.000+48%398834140.000398834140.0000%1149285280.000-65%387029855.000+3%387029855.000+3%
Net Profit Margin---151.990-151.9900%-8.716-94%-43.144-72%-43.144-72%
Operating Margin---163.330-163.3300%-8.442-95%-45.837-72%-45.837-72%
Operating Ratio--166.497166.4970%8.452+1870%49.365+237%49.365+237%
Pb Ratio3.525+48%1.8281.8280%4.131-56%1.490+23%1.490+23%
Pe Ratio-8.381-93%-4.347-4.3470%-17.161+295%-5.377+24%-5.377+24%
Price Per Share15.310+48%7.9407.9400%22.880-65%7.705+3%7.705+3%
Price To Free Cash Flow Ratio-10.565-93%-5.479-5.4790%-29.062+430%-8.635+58%-8.635+58%
Price To Total Gains Ratio-12.805-93%-6.641-6.6410%3.769-276%-1.436-78%-1.436-78%
Quick Ratio--27.39827.3980%30.210-9%19.682+39%19.682+39%
Return On Assets---0.371-0.3710%-0.236-36%-0.504+36%-0.504+36%
Return On Equity---0.405-0.4050%-0.244-40%-0.162-60%-0.162-60%
Total Gains Per Share---1.196-1.1960%6.070-120%1.086-210%1.086-210%
Usd Book Value--218162000.000218162000.0000%278220000.000-22%115359000.000+89%115359000.000+89%
Usd Book Value Change Per Share---1.196-1.1960%6.070-120%1.086-210%1.086-210%
Usd Book Value Per Share--4.3434.3430%5.539-22%2.297+89%2.297+89%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.827-1.8270%-1.333-27%-0.914-50%-0.914-50%
Usd Free Cash Flow---72788000.000-72788000.0000%-39546000.000-46%-32780500.000-55%-32780500.000-55%
Usd Free Cash Flow Per Share---1.449-1.4490%-0.787-46%-0.653-55%-0.653-55%
Usd Free Cash Flow To Equity Per Share---1.244-1.2440%5.280-124%1.082-215%1.082-215%
Usd Market Cap769036610.000+48%398834140.000398834140.0000%1149285280.000-65%387029855.000+3%387029855.000+3%
Usd Price Per Share15.310+48%7.9407.9400%22.880-65%7.705+3%7.705+3%
Usd Profit---88458000.000-88458000.0000%-67999000.000-23%-45209500.000-49%-45209500.000-49%
Usd Revenue--582000.000582000.0000%7802000.000-93%2500000.000-77%2500000.000-77%
Usd Total Gains Per Share---1.196-1.1960%6.070-120%1.086-210%1.086-210%
 EOD+5 -3MRQTTM+0 -0YOY+2 -315Y+9 -2410Y+9 -24

4.2. Fundamental Score

Let's check the fundamental score of Icosavax Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.381
Price to Book Ratio (EOD)Between0-13.525
Net Profit Margin (MRQ)Greater than0-151.990
Operating Margin (MRQ)Greater than0-163.330
Quick Ratio (MRQ)Greater than127.398
Current Ratio (MRQ)Greater than116.240
Debt to Asset Ratio (MRQ)Less than10.086
Debt to Equity Ratio (MRQ)Less than10.094
Return on Equity (MRQ)Greater than0.15-0.405
Return on Assets (MRQ)Greater than0.05-0.371
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Icosavax Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.408
Ma 20Greater thanMa 5015.315
Ma 50Greater thanMa 10015.450
Ma 100Greater thanMa 20012.090
OpenGreater thanClose15.310
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets238,677
Total Liabilities20,515
Total Stockholder Equity218,162
 As reported
Total Liabilities 20,515
Total Stockholder Equity+ 218,162
Total Assets = 238,677

Assets

Total Assets238,677
Total Current Assets223,913
Long-term Assets14,764
Total Current Assets
Cash And Cash Equivalents 58,846
Short-term Investments 159,461
Other Current Assets 4,545
Total Current Assets  (as reported)223,913
Total Current Assets  (calculated)222,852
+/- 1,061
Long-term Assets
Property Plant Equipment 14,764
Long-term Assets  (as reported)14,764
Long-term Assets  (calculated)14,764
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,788
Long-term Liabilities6,727
Total Stockholder Equity218,162
Total Current Liabilities
Short-term Debt 2,137
Accounts payable 2,892
Other Current Liabilities 8,759
Total Current Liabilities  (as reported)13,788
Total Current Liabilities  (calculated)13,788
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt6,658
Other Liabilities 69
Long-term Liabilities  (as reported)6,727
Long-term Liabilities  (calculated)6,727
+/-0
Total Stockholder Equity
Common Stock6
Retained Earnings -185,827
Accumulated Other Comprehensive Income -403
Other Stockholders Equity 404,386
Total Stockholder Equity (as reported)218,162
Total Stockholder Equity (calculated)218,162
+/-0
Other
Capital Stock6
Cash and Short Term Investments 218,307
Common Stock Shares Outstanding 39,725
Liabilities and Stockholders Equity 238,677
Net Debt -50,051
Net Invested Capital 218,162
Net Tangible Assets 218,162
Net Working Capital 210,125
Property Plant and Equipment Gross 14,764
Short Long Term Debt Total 8,795



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-31
> Total Assets 
23,288
16,170
287,629
238,677
238,677287,62916,17023,288
   > Total Current Assets 
23,288
16,160
286,553
223,913
223,913286,55316,16023,288
       Cash And Cash Equivalents 
23,079
13,114
279,082
58,846
58,846279,08213,11423,079
       Short-term Investments 
0
0
0
159,461
159,461000
       Other Current Assets 
209
662
5,829
4,545
4,5455,829662209
   > Long-term Assets 
0
10
1,076
14,764
14,7641,076100
       Property Plant Equipment 
0
10
1,076
14,764
14,7641,076100
> Total Liabilities 
31,531
42,873
9,409
20,515
20,5159,40942,87331,531
   > Total Current Liabilities 
1,223
5,834
9,238
13,788
13,7889,2385,8341,223
       Short-term Debt 
0
0
0
2,137
2,137000
       Accounts payable 
799
1,918
3,899
2,892
2,8923,8991,918799
       Other Current Liabilities 
424
1,532
4,757
8,759
8,7594,7571,532424
   > Long-term Liabilities 
30,308
37,039
171
6,727
6,72717137,03930,308
       Long term Debt 
0
4,947
0
0
004,9470
       Capital Lease Obligations Min Short Term Debt
0
0
0
6,658
6,658000
       Other Liabilities 
246
2,030
171
69
691712,030246
       Long-term Liabilities Other 
246
426
171
69
69171426246
> Total Stockholder Equity
-8,243
-26,703
278,220
218,162
218,162278,220-26,703-8,243
   Common Stock
1
2
5
6
6521
   Retained Earnings -185,827-94,069-27,098-8,244
   Accumulated Other Comprehensive Income -403-287,62900
   Capital Surplus 0000
   Treasury Stock0000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-105,883
Operating Income-105,883-105,883
 
Operating Expense (+$)
Research Development70,044
Selling General Administrative35,839
Selling And Marketing Expenses-
Operating Expense105,883105,883
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-9,171
Net Interest Income9,171
 
Pretax Income (+$)
Operating Income-105,883
Net Interest Income9,171
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-96,712-105,883
EBIT - interestExpense = 0
-96,712
-96,712
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--96,712
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-96,712
Tax Provision--
Net Income From Continuing Ops-96,712-96,712
Net Income-96,712
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--9,171
 

Technical Analysis of Icosavax
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Icosavax. The general trend of Icosavax is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Icosavax's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Icosavax Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 15.55 < 15.58 < 15.78.

The bearish price targets are: 15.20 > 15.18 > 15.17.

Tweet this
Icosavax Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Icosavax Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Icosavax Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Icosavax Inc. The current macd is 0.06266118.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Icosavax price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Icosavax. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Icosavax price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Icosavax Inc Daily Moving Average Convergence/Divergence (MACD) ChartIcosavax Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Icosavax Inc. The current adx is 26.96.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Icosavax shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Icosavax Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Icosavax Inc. The current sar is 16.11.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Icosavax Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Icosavax Inc. The current rsi is 55.41. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Icosavax Inc Daily Relative Strength Index (RSI) ChartIcosavax Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Icosavax Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Icosavax price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Icosavax Inc Daily Stochastic Oscillator ChartIcosavax Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Icosavax Inc. The current cci is -11.88242652.

Icosavax Inc Daily Commodity Channel Index (CCI) ChartIcosavax Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Icosavax Inc. The current cmo is -4.7858833.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Icosavax Inc Daily Chande Momentum Oscillator (CMO) ChartIcosavax Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Icosavax Inc. The current willr is -71.05263158.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Icosavax is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Icosavax Inc Daily Williams %R ChartIcosavax Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Icosavax Inc.

Icosavax Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Icosavax Inc. The current atr is 0.11186994.

Icosavax Inc Daily Average True Range (ATR) ChartIcosavax Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Icosavax Inc. The current obv is 41,141,355.

Icosavax Inc Daily On-Balance Volume (OBV) ChartIcosavax Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Icosavax Inc. The current mfi is 8.14360504.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Icosavax Inc Daily Money Flow Index (MFI) ChartIcosavax Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Icosavax Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-10-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Icosavax Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Icosavax Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.408
Ma 20Greater thanMa 5015.315
Ma 50Greater thanMa 10015.450
Ma 100Greater thanMa 20012.090
OpenGreater thanClose15.310
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Icosavax with someone you think should read this too:
  • Are you bullish or bearish on Icosavax? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Icosavax? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Icosavax Inc

I send you an email if I find something interesting about Icosavax Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Icosavax Inc.

Receive notifications about Icosavax Inc in your mailbox!